Home
Search
Study Topics
Glossary
Full Text View
Tabular View
Contacts and Locations
No Study Results Posted
Related Studies
ABX-EGF in Combination With Paclitaxel and Carboplatin for the Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC)
This study has been completed.
Study NCT00034346. Last updated on December 20, 2007. Information provided by Amgen
Please refer to this study by its ClinicalTrials.gov identifier: NCT00034346
Sponsors and Collaborators
Amgen
Investigators
Study Director:
MD
Amgen
U.S. National Library of Medicine
,
Contact Help Desk
U.S. National Institutes of Health
,
U.S. Department of Health & Human Services
,
USA.gov
,
Copyright
,
Privacy
,
Accessibility
,
Freedom of Information Act
Links to all studies - primarily for crawlers